Related Experiment Video
Updated: Jan 23, 2026

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
Published on: January 22, 2011
Precision Oncology: Three Small Steps Forward
Hannah C Wise1, David B Solit2
1Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Abstract:
Only a subset of cancer patients currently benefit from personalized treatment approaches. Detection of actionable drug targets in cell-free DNA, more comprehensive molecular profiling integrating transcriptional analyses, and personalized combination regimens all hold promise in expanding the benefits of personalized oncology to larger numbers of cancer patients.
Insights
Personalized cancer treatments are limited. Detecting drug targets in cell-free DNA, comprehensive molecular profiling, and combination therapies can expand personalized oncology benefits.
Area of Science:
- Oncology
- Molecular Biology
- Genomics
Background:
- Personalized oncology aims to tailor cancer treatments to individual patients.
- Current personalized approaches benefit only a limited patient population.
- Advances in molecular diagnostics are crucial for expanding treatment options.
Purpose of the Study:
- To explore strategies for broadening the reach of personalized cancer therapies.
- To highlight the potential of novel molecular profiling techniques.
- To discuss the role of combination regimens in precision oncology.
Main Methods:
- Review of current literature on personalized oncology.
- Analysis of emerging technologies for molecular profiling, including cell-free DNA analysis.
- Evaluation of strategies for developing personalized combination therapies.
Main Results:
- Cell-free DNA analysis enables the detection of actionable drug targets.
- Integrating transcriptional analyses provides a more comprehensive molecular profile.
- Personalized combination regimens show promise for improved patient outcomes.
Conclusions:
- Expanding personalized oncology requires advancements in target detection and profiling.
- Comprehensive molecular profiling, including transcriptomics, is key.
- Personalized combination therapies represent a promising avenue for broader patient benefit.
More Related Videos
06:37Multispectral Real-time Fluorescence Imaging for Intraoperative Detection of the Sentinel Lymph Node in Gynecologic Oncology
Published on: October 20, 2010
10:49Automated Multiplex Immunofluorescence Panel for Immuno-oncology Studies on Formalin-fixed Carcinoma Tissue Specimens
Published on: January 21, 2019
Related Concept Videos
Uncertainty in Measurement: Accuracy and Precision
Accuracy and Precision
Rate-Determining Steps
In a multistep reaction mechanism, one of the elementary steps progresses significantly slower than the others. This slowest step is called the rate-limiting step (or rate-determining step). A reaction cannot proceed faster than its slowest step, and hence, the rate-determining step limits the overall reaction rate.
The concept of rate-determining step can be understood from the analogy of a 4-lane freeway with a short-stretch of traffic-bottleneck caused due to...
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Steps in Outbreak Investigation
Steps in the Modeling Process
Attention is the first necessary component for observational learning. It involves focusing on what the model is doing and saying. For example, if you decide to take a drawing class to enhance your skills, you need to pay close attention to the instructor's words and hand movements. The characteristics of the model significantly...